Cargando…
Study of Endothelial Dysfunction in Patients With Non-alcoholic Fatty Liver Disease
Background Metabolic syndrome (syndrome X) is the name for a group of risk factors that raises your risk for heart disease and other health problems, such as diabetes and stroke. Dilatation of blood vessels following stress is a function of vasodilators produced by the endothelium. Flow-mediated vas...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cureus
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8687804/ https://www.ncbi.nlm.nih.gov/pubmed/34950560 http://dx.doi.org/10.7759/cureus.20515 |
_version_ | 1784618250011672576 |
---|---|
author | Jose, Nijin P.K, Vasant Kulirankal, Kiran G |
author_facet | Jose, Nijin P.K, Vasant Kulirankal, Kiran G |
author_sort | Jose, Nijin |
collection | PubMed |
description | Background Metabolic syndrome (syndrome X) is the name for a group of risk factors that raises your risk for heart disease and other health problems, such as diabetes and stroke. Dilatation of blood vessels following stress is a function of vasodilators produced by the endothelium. Flow-mediated vasodilation assesses endothelial function. In the case of endothelial dysfunction, flow-mediated vasodilation is impaired, resulting in decreased or even absence of vasodilation following stress. The easy availability of ultrasound machines nowadays and the non-invasive nature of the test make this a practical test for assessing endothelial dysfunction and the risk of cardiovascular diseases. Various studies have confirmed the presence of impaired flow-mediated vasodilation in patients with coronary artery disease. However, the presence of impaired flow-mediated vasodilation in individuals with risk factors but no cardiovascular diseases can prove that this can be used to predict individuals at risk. This study tries to confirm the presence of endothelial dysfunction in patients with non-alcoholic fatty liver disease (NAFLD) attending a tertiary center hospital in Kochi. Objectives The study's main aim is to compare flow-mediated dilatation in patients with NAFLD and normal individuals. Materials and methods The comparative study was conducted among 50 patients attending various outpatient departments in Amrita Institute of Medical Sciences, Kochi. History and examination of cases and controls and relevant investigations were done after obtaining consent. In addition, both groups underwent measurement of flow-mediated vasodilation in the radiology department. Data were entered in Microsoft Excel and were analyzed using SPSS. Results Flow-mediated vasodilation was found to be less in patients with fatty liver (7.37 ± 2.75) when compared to individuals with normal liver (12.41 ± 3.71). In addition, flow-mediated vasodilatation was inversely proportional to BMI and age. Conclusion This study has proved that there will be endothelial dysfunction in NAFLD, as shown by the decrease in flow-mediated vasodilation when compared with normal liver. |
format | Online Article Text |
id | pubmed-8687804 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Cureus |
record_format | MEDLINE/PubMed |
spelling | pubmed-86878042021-12-22 Study of Endothelial Dysfunction in Patients With Non-alcoholic Fatty Liver Disease Jose, Nijin P.K, Vasant Kulirankal, Kiran G Cureus Internal Medicine Background Metabolic syndrome (syndrome X) is the name for a group of risk factors that raises your risk for heart disease and other health problems, such as diabetes and stroke. Dilatation of blood vessels following stress is a function of vasodilators produced by the endothelium. Flow-mediated vasodilation assesses endothelial function. In the case of endothelial dysfunction, flow-mediated vasodilation is impaired, resulting in decreased or even absence of vasodilation following stress. The easy availability of ultrasound machines nowadays and the non-invasive nature of the test make this a practical test for assessing endothelial dysfunction and the risk of cardiovascular diseases. Various studies have confirmed the presence of impaired flow-mediated vasodilation in patients with coronary artery disease. However, the presence of impaired flow-mediated vasodilation in individuals with risk factors but no cardiovascular diseases can prove that this can be used to predict individuals at risk. This study tries to confirm the presence of endothelial dysfunction in patients with non-alcoholic fatty liver disease (NAFLD) attending a tertiary center hospital in Kochi. Objectives The study's main aim is to compare flow-mediated dilatation in patients with NAFLD and normal individuals. Materials and methods The comparative study was conducted among 50 patients attending various outpatient departments in Amrita Institute of Medical Sciences, Kochi. History and examination of cases and controls and relevant investigations were done after obtaining consent. In addition, both groups underwent measurement of flow-mediated vasodilation in the radiology department. Data were entered in Microsoft Excel and were analyzed using SPSS. Results Flow-mediated vasodilation was found to be less in patients with fatty liver (7.37 ± 2.75) when compared to individuals with normal liver (12.41 ± 3.71). In addition, flow-mediated vasodilatation was inversely proportional to BMI and age. Conclusion This study has proved that there will be endothelial dysfunction in NAFLD, as shown by the decrease in flow-mediated vasodilation when compared with normal liver. Cureus 2021-12-19 /pmc/articles/PMC8687804/ /pubmed/34950560 http://dx.doi.org/10.7759/cureus.20515 Text en Copyright © 2021, Jose et al. https://creativecommons.org/licenses/by/3.0/This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. |
spellingShingle | Internal Medicine Jose, Nijin P.K, Vasant Kulirankal, Kiran G Study of Endothelial Dysfunction in Patients With Non-alcoholic Fatty Liver Disease |
title | Study of Endothelial Dysfunction in Patients With Non-alcoholic Fatty Liver Disease |
title_full | Study of Endothelial Dysfunction in Patients With Non-alcoholic Fatty Liver Disease |
title_fullStr | Study of Endothelial Dysfunction in Patients With Non-alcoholic Fatty Liver Disease |
title_full_unstemmed | Study of Endothelial Dysfunction in Patients With Non-alcoholic Fatty Liver Disease |
title_short | Study of Endothelial Dysfunction in Patients With Non-alcoholic Fatty Liver Disease |
title_sort | study of endothelial dysfunction in patients with non-alcoholic fatty liver disease |
topic | Internal Medicine |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8687804/ https://www.ncbi.nlm.nih.gov/pubmed/34950560 http://dx.doi.org/10.7759/cureus.20515 |
work_keys_str_mv | AT josenijin studyofendothelialdysfunctioninpatientswithnonalcoholicfattyliverdisease AT pkvasant studyofendothelialdysfunctioninpatientswithnonalcoholicfattyliverdisease AT kulirankalkirang studyofendothelialdysfunctioninpatientswithnonalcoholicfattyliverdisease |